SOURCES SOUGHT
65 -- GonaCon Immunocontraceptive Vaccine - Sources Sought Notice
- Notice Date
- 1/21/2010
- Notice Type
- Sources Sought
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Agriculture, Animal and Plant Health Inspection Service, Administrative Services Division/Contracting, 100 North 6TH Street, Butler Square 5TH Floor, Minneapolis, Minnesota, 55403
- ZIP Code
- 55403
- Solicitation Number
- AG-6395-S-10-0042
- Point of Contact
- Nathan Johnson,
- E-Mail Address
-
nathan.d.johnson@aphis.usda.gov
(nathan.d.johnson@aphis.usda.gov)
- Small Business Set-Aside
- N/A
- Description
- Sources Sought Notice and SOW The United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services (WS) is seeking interested parties capable of manufacturing GonaCon Immunocontraceptive Vaccine. Manufacturing must be conducted under Good Laboratory Practices, Good Manufacturing Practices or similar ISO certifications. Manufacturing would be required at a minimum of twice per year. The GonaConTM Immunocontraceptive Vaccine formulation consists of a multi-step process where mammalian Gonadotropin Releasing Hormone (GnRH) is conjugated to a mollusk hemocyanin and emulsified in a mineral oil based adjuvant to form the final product (Figure 1). Prior to conjugation the hemocyanin carrier protein must be maleimide activated. Dialysis is performed to remove excess maleimide formed after the activation. GnRH is then conjugated to the maleimide activated hemocyanin. The aduvant is formulated separately from the rest of the vaccine by preparing a suspension of killed bacteria in light mineral oil. Final preparation of the vaccine involves vortex mixing the peptide/hemocyanin conjugate with the adjuvant preparation and producing the final emulsion by running the preparation through an emulsifier. The final emulsion is loaded into 3 ml polyethylene syringes. Individual syringes are then labeled, packaged and shipped to a predetermined USDA facility. All phases of manufacturing must be conducted under clean room conditions. Specialized equipment requirements include a spectrophotometer for quality assurance monitoring, and a emulsification instrument capable of producing 6000 psi (e.g., Microfluidics Model M110L or equivalent).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USDA/APHIS/Contracting/AG-6395-S-10-0042/listing.html)
- Record
- SN02046405-W 20100123/100121234839-760c5aa0b895f7afbfefc1dda4f014c4 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |